Overview
Peter Keane practices practicing medicine in Birmingham, United Kingdom.
Mr. Keane is highly rated in 1 condition, according to our data. His clinical expertise encompasses RUNX1 Familial Platelet Disorder, Acute Myeloid Leukemia (AML), and Leukemia.
He is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Peter Keane
Is Peter Keane a top-rated expert for RUNX1 Familial Platelet Disorder?
MediFind is an objective health platform that identifies experts based on real-world data. Peter Keane is classified as an Advanced expert for RUNX1 Familial Platelet Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Peter Keane participate in research or clinical trials?
Yes. Peter Keane has published 18 articles and abstracts on conditions like RUNX1 Familial Platelet Disorder. You can view a list of Peter Keane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RUNX1 Familial Platelet Disorder
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Keane isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Keane isExperienced. Learn about Leukemia.